blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2909169

EP2909169 - CRYSTALLINE PHASE OF (3S,3S') 4,4'-DISULFANEDIYLBIS(3-AMINOBUTANE 1-SULFONIC ACID) WITH L-LYSINE [Right-click to bookmark this link]
Former [2015/35]CRYSTALLINE PHASE OF (3S.3S') 4,4'-DISULFANEDIYLBIS(3-AMINOBUTANE 1 -SULFONIC ACID) WITH L-LYSINE
[2017/31]
StatusNo opposition filed within time limit
Status updated on  09.11.2018
Database last updated on 02.11.2024
FormerThe patent has been granted
Status updated on  01.12.2017
FormerGrant of patent is intended
Status updated on  31.07.2017
FormerExamination is in progress
Status updated on  25.11.2016
Most recent event   Tooltip03.10.2024Change - lapse in a contracting statepublished on 06.11.2024 [2024/45]
Applicant(s)For all designated states
Quantum Genomics
Bãtiment L'Odyssée 2-12, chemin des Femmes
91300 Massy / FR
[2015/35]
Inventor(s)01 / BALAVOINE, Fabrice
48, rue de Voullé
F-75002 Paris / FR
02 / SCHNEIDER, Jean-Marie
11 chemin des Merles
F-78200 Magnanville / FR
03 / COQUEREL, Gérard
192 rue de l'Eglise
F-76520 Boos / FR
04 / COUVRAT, Nicolas
26 route de l'Eure
F-27340 Les Damps / FR
 [2015/35]
Representative(s)Cabinet Becker et Associés
25, rue Louis le Grand
75002 Paris / FR
[2015/35]
Application number, filing date13779603.322.10.2013
[2015/35]
WO2013EP72028
Priority number, dateEP2012030630722.10.2012         Original published format: EP 12306307
[2015/35]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2014064077
Date:01.05.2014
Language:EN
[2014/18]
Type: A1 Application with search report 
No.:EP2909169
Date:26.08.2015
Language:EN
The application published by WIPO in one of the EPO official languages on 01.05.2014 takes the place of the publication of the European patent application.
[2015/35]
Type: B1 Patent specification 
No.:EP2909169
Date:03.01.2018
Language:EN
[2018/01]
Search report(s)International search report - published on:EP01.05.2014
ClassificationIPC:C07C323/66, A61K31/145, A61P9/12, C07C229/26
[2015/35]
CPC:
C07C229/26 (EP,US); C07C319/28 (US); A61K31/145 (EP,US);
A61P13/02 (EP); A61P13/12 (EP); A61P25/00 (EP);
A61P27/06 (EP); A61P3/00 (EP); A61P9/00 (EP);
A61P9/04 (EP); A61P9/10 (EP); A61P9/12 (EP);
C07C227/42 (US); C07C323/66 (EP,US); C07B2200/13 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2015/35]
Extension statesBA24.03.2015
ME24.03.2015
TitleGerman:KRISTALLINE PHASE VON (3S,3S') 4,4'-DISULFANDIYLBIS (3-AMINOBUTAN 1-SULFONSÄURE) MIT L-LYSIN[2017/31]
English:CRYSTALLINE PHASE OF (3S,3S') 4,4'-DISULFANEDIYLBIS(3-AMINOBUTANE 1-SULFONIC ACID) WITH L-LYSINE[2017/31]
French:PHASE CRISTALLINE DE (3S, 3S') 4,4'-DISULFANEDIYLBIS (ACIDE 3-AMINOBUTANE 1-SULFONIQUE) AVEC DE LA L-LYSINE[2017/31]
Former [2015/35]KRISTALLINE PHASE VON (3S,3S')-4,4'-DISULFANDIYLBIS-(3-AMINOBUTAN 1-SULFONSÄURE) MIT L-LYSIN
Former [2015/35]CRYSTALLINE PHASE OF (3S.3S') 4,4'-DISULFANEDIYLBIS(3-AMINOBUTANE 1 -SULFONIC ACID) WITH L-LYSINE
Former [2015/35]PHASE CRISTALLINE DE L'ACIDE (3S.3S') 4,4'-DISULFANEDIYLBIS(3-AMINOBUTANE 1-SULFONIQUE) AVEC LA L-LYSINE
Entry into regional phase24.03.2015National basic fee paid 
24.03.2015Designation fee(s) paid 
24.03.2015Examination fee paid 
Examination procedure24.03.2015Examination requested  [2015/35]
30.11.2015Amendment by applicant (claims and/or description)
28.11.2016Despatch of a communication from the examining division (Time limit: M04)
16.03.2017Reply to a communication from the examining division
01.08.2017Communication of intention to grant the patent
21.11.2017Fee for grant paid
21.11.2017Fee for publishing/printing paid
21.11.2017Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  28.11.2016
Opposition(s)05.10.2018No opposition filed within time limit [2018/50]
Fees paidRenewal fee
15.10.2015Renewal fee patent year 03
03.10.2016Renewal fee patent year 04
17.10.2017Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Former [2022/31]AL03.01.2018
Cited inInternational search[AD]WO2004007441  (INST NAT SANTE RECH MED [FR], et al) [AD] 1,5,14,15 * claims 1-4 * * abstract * * page 5, line 5 - line 19 *;
 [A]WO2005014535  (INST NAT SANTE RECH MED [FR], et al) [A] 1,5,14,15 * page 2, line 14 - page 3, line 17 ** page 7, line 10 - line 31 *;
 [AD]WO2012045849  (QUANTUM GENOMICS [FR], et al) [AD] 1,5,14,15 * page 6, line 6 - line 17 * * page 1, line 4 - line 15 * * claim 18 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.